Uniphar PLC (UPR) Share Price & Analysis

18 Followers

UPR Stock Chart & Stats

GBX 361.00GBX 0.00(0.00%)

At close: Nov 12 4:30 PM GMT

Day’s Range: GBX 356.00 - GBX 366.00
52-Week Range: GBX 294.00 - GBX 428.00
Previous Close: GBX 361.00
Volume: N/A
Average Volume (3M): 41.36K
Market Cap: GBP 952.28M
Enterprise Value: GBP 1.59B
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): GBP 182.54M
Price to Earnings (P/E): 21.0
Beta: 0.64
Next Earnings: Mar 02, 2027 (Est.)
EPS Estimate: 0.13
Last Dividend Ex-Date: Sep 17, 2026
Dividend Yield: 0.49%

Uniphar PLC News

INmune Bio Enters Agreement to Distribute Its Ebstrocel Treatment

INmune Bio, Inc. ($INMB), a clinical-stage biotechnology company focused on developing novel immunotherapies, announced today that it has entered into a Master Services Agreement with Uniphar Durbin Ireland Limited (Uniphar)

3w agoINMB UPR

Allianz Global Investors Takes 3.96% Stake in Uniphar plc

Uniphar PLC ( ($GB:UPR) ) has provided an announcement. Uniphar plc has disclosed that Allianz Global Investors GmbH has accumulated a holding of 10,280,876 ordinary shares in the company, representing

1M ago0NR UPR

Uniphar posts robust H1 2026 results as all divisions grow and investment ramps up

Uniphar PLC ( ($GB:UPR) ) has provided an announcement. Uniphar reported a strong first-half performance to 30 June 2026, with revenue rising to €1.59bn and gross profit up 7.7%, 6.9%

2M ago0NR UPR

Uniphar lifts H1 earnings, delays distribution hub to de-risk rollout

An announcement from Uniphar PLC ( ($GB:UPR) ) is now available. Uniphar reported approximately 11% adjusted EPS growth for the first half of 2026, driven by around 7% organic gross

3M ago0NR UPR

Uniphar lifts H1 earnings, delays Irish hub to de-risk rollout

Uniphar PLC ( ($GB:UPR) ) just unveiled an update. Uniphar reported approximately 11% adjusted EPS growth for the first half of 2026, driven by around 7% organic gross profit growth

3M ago0NR UPR

Uniphar Switches Nominated Adviser to J&E Davy After Davy Group Restructuring

An update from Uniphar PLC ( ($GB:UPR) ) is now available. Uniphar plc has appointed J&E Davy as its new Nominated Adviser, following an internal restructuring within the Davy Group.

5M ago0NR UPR

Uniphar Chairman Maurice Pratt Sells 50,000 Shares on Euronext Dublin

An announcement from Uniphar PLC ( ($GB:UPR) ) is now available. Uniphar plc has disclosed a share transaction by its non-executive chairman, Maurice Pratt, in line with market abuse regulation

6M ago0NR UPR

Uniphar Investors Back AGM Resolutions but Block Extended Pre-emption Powers

Uniphar PLC ( ($GB:UPR) ) has issued an update. Shareholders of Uniphar plc approved the company’s financial statements, a €3.4m final dividend and the re-election of all directors at its

6M ago0NR UPR

Uniphar Delivers Record Organic Growth and Reaffirms 2028 EBITDA Target

Uniphar PLC ( ($GB:UPR) ) just unveiled an update. Uniphar reported that 2025 was its strongest year of organic expansion since listing, with about 9% organic gross profit growth and

6M ago0NR UPR

Allianz Global Investors Takes 4.82% Stake in Uniphar plc

Uniphar PLC ( ($GB:UPR) ) has issued an update. Uniphar plc has disclosed that Allianz Global Investors GmbH has acquired a significant holding in the company, now owning 12,514,477 ordinary

6M ago0NR UPR

UPR FAQ

What was Uniphar PLC’s price range in the past 12 months?

Uniphar PLC lowest share price was 294.00 p and its highest was 428.00 p in the past 12 months.

What is Uniphar PLC’s market cap?

Uniphar PLC’s market cap is £952.28M.

When is Uniphar PLC’s upcoming earnings report date?

Uniphar PLC’s next earnings report is estimated for Mar 02, 2027 (not yet confirmed), which is in 109 days.

How were Uniphar PLC’s earnings last quarter?

Uniphar PLC released its earnings results on Sep 08, 2026. The company reported 0.091 p earnings per share for the quarter, missing the consensus estimate of 0.121 p by -0.03 p.

Is Uniphar PLC overvalued?

According to Wall Street analysts Uniphar PLC’s price is currently Undervalued.

Does Uniphar PLC pay dividends?

Uniphar PLC pays a semiannual dividend of 0.619 p which represents an annual dividend yield of 0.49%. See more information on Uniphar PLC dividends here

What is Uniphar PLC’s EPS estimate?

Uniphar PLC’s EPS estimate is 0.13.

How many shares outstanding does Uniphar PLC have?

Uniphar PLC has 259,574,300 shares outstanding.

What happened to Uniphar PLC’s price movement after its last earnings report?

Uniphar PLC reported an EPS of 0.091 p in its last earnings report, missing expectations of 0.121 p. Following the earnings report the stock price went up 1.408%.

Which hedge fund is a major shareholder of Uniphar PLC?

Currently, no hedge funds are holding shares in GB:UPR

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Uniphar PLC

Uniphar plc functions as a multifaceted healthcare solutions provider, serving markets across the Republic of Ireland, the United Kingdom, and various international territories. Its operations are segmented into three primary divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. The Commercial & Clinical division provides outsourced services encompassing sales, marketing, and integrated account management for pharmaceutical and medical device manufacturers, also managing the distribution and support for medical device producers. The Product Access division facilitates access to pharmaceutical and medical treatments through on-demand services, fostering vital connections between manufacturers and healthcare stakeholders; additionally, its exclusive access services establish tailored distribution agreements for crucial pharmaceutical brands. The Supply Chain & Retail division manages the pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary practices, and also oversees a network of retail pharmacies operating under the Life, Allcare, and Hickey's banners. Beyond its core divisional activities, Uniphar delivers a broad spectrum of specialized services, including pharmacy support, comprehensive pharmaceutical supply chain management, specialist nursing and infusion services, medical device distribution, and healthcare technology solutions. It further extends its expertise through data intelligence, consultancy, pharmaceutical advisory, and medical affairs services, alongside online pharmacy operations, product fostering, and data analytics for the pharmaceutical sector. Established in 1967, Uniphar plc maintains its headquarters in Dublin, Ireland.

Uniphar PLC (UPR) Earnings & Revenues

Historic Earnings Reports

UPR Stock 12 Month Forecast

Average Price Target

459.63▲(27.32% Upside)

Past 12 Months12 Month ForecastFeb2026Nov2026

High501.42

Average459.63

Low417.85

Detailed Analyst Forecast >

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	14	2	6
Technical Analysis	2	2	6
Moving Averages	12	0	0

Technical Analysis >

Similar Stocks

Stocks similar to GB:UPR
Company	Price & Change	Follow
GB:EKFEKF Diagnostics Holdings
GB:HIKHikma Pharmaceuticals
GB:PRTCPureTech Health

Compare GB:UPR Stocks >

Ownership Overview

5.09% Insiders
1.15% Mutual Funds
91.43% Public Companies and Individual Investors

Detailed Ownership Overview >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft

UPR Stock Chart & Stats

Uniphar PLC News

INmune Bio Enters Agreement to Distribute Its Ebstrocel Treatment

Allianz Global Investors Takes 3.96% Stake in Uniphar plc

Uniphar posts robust H1 2026 results as all divisions grow and investment ramps up

Uniphar lifts H1 earnings, delays distribution hub to de-risk rollout

Uniphar lifts H1 earnings, delays Irish hub to de-risk rollout

Uniphar Switches Nominated Adviser to J&E Davy After Davy Group Restructuring

Uniphar Chairman Maurice Pratt Sells 50,000 Shares on Euronext Dublin

Uniphar Investors Back AGM Resolutions but Block Extended Pre-emption Powers

Uniphar Delivers Record Organic Growth and Reaffirms 2028 EBITDA Target

Allianz Global Investors Takes 4.82% Stake in Uniphar plc

UPR FAQ

Company Description

Uniphar PLC

Uniphar PLC (UPR) Earnings & Revenues

UPR Stock 12 Month Forecast

Average Price Target

Technical Analysis

Overall Consensus

Similar Stocks

Ownership Overview

Popular Stocks

Become an Expert with TipRanks Premium